IL6 and COVID-19: Biomarkers such as IL-6, IL-8, PAI-1, and ICAM-1, key to class designation in hyper- and hypo-inflammatory ARDS [20], were notably less class separating in severe COVID-19 subtypes, potentially rendering them less useful in phenotyping this patient population.